EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Jazz Pharmaceuticals PLC (JAZZ) EBITDA Margin data is not available.
| Income Statement Financials | |
$1.05B |
|
$-718.47M |
|
$116.27M |
|
$929.44M |
|
$1.73B |
|
$-686.39M |
|
$-49.16M |
|
$-735.55M |
|
$-735.55M |
|
$-718.38M |
|
$-718.47M |
|
$-718.47M |
|
$-718.38M |
|
$-686.39M |
|
$-512.38M |
|
61.19M |
|
61.19M |
|
$-11.74 |
|
$-11.74 |
|
| Balance Sheet Financials | |
$3.35B |
|
$184.97M |
|
$7.59B |
|
$10.94B |
|
$2.07B |
|
$4.34B |
|
$5.17B |
|
$7.24B |
|
$3.71B |
|
$-2.91B |
|
$3.71B |
|
60.64M |
|
| Cash Flow Statement Financials | |
$518.64M |
|
$-809.95M |
|
$-937.99M |
|
$2.41B |
|
$1.19B |
|
$-1.22B |
|
$132.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.62 |
|
-- |
|
-- |
|
0.54 |
|
1.45 |
|
88.88% |
|
-65.64% |
|
-65.64% |
|
|
EBITDA Margin |
-- |
-70.34% |
|
-68.71% |
|
$491.79M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.23 |
|
1.46 |
|
61.45 |
|
-19.38% |
|
24.72% |
|
-6.56% |
|
-8.93% |
|
$61.12 |
|
$8.04 |
|
$8.48 |
|